Followers | 60 |
Posts | 3117 |
Boards Moderated | 0 |
Alias Born | 09/27/2009 |
Wednesday, February 08, 2017 1:23:11 PM
from the most recent headline :
" Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista™
(oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic ..... "
my 2 questions are ,
Is the extended release unique to Rexista ?
and because the headline said : " an Abuse Deterrent " ,
Would this filing have Rexista using the PODRAS technology ?
TIA
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM